Document Detail

Fluoxetine promotes gliogenesis during neural differentiation in mouse embryonic stem cells.
MedLine Citation:
PMID:  20857517     Owner:  NLM     Status:  In-Process    
Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for treatment of mood disorders and depression, even during pregnancy and lactation. SSRIs are thought to be much safer than tricyclic antidepressants, with a low risk of embryonic toxicity. Several recent studies, however, have reported that fetal exposure to SSRIs increases the risk of adverse effects during fetal and neonatal development. This is consistent with our previous finding that fluoxetine, a prototypical SSRI, profoundly affected the viability of cultured embryonic stem (ES) cells as well as their ability to differentiate into cardiomyocytes. Furthermore, we found that fluoxetine induced fluctuations in ectodermal marker gene expression during ES cell differentiation, which suggests that fluoxetine may affect neural development. In the present study, we investigated the effects of fluoxetine on the process of differentiation from ES cells into neural cells using the stromal cell-derived inducing activity (SDIA) method. Fluoxetine treatment was found to enhance the expression of glial marker genes following neural differentiation, as observed by immunocytochemical analysis or quantitative RT-PCR. The promoter activity of glial marker genes was also significantly enhanced when cells were treated with fluoxetine, as observed by luciferase reporter assay. The expression of neuronal markers during ES cell differentiation into neural cells, on the other hand, was inhibited by fluoxetine treatment. In addition, FACS analysis revealed an increased population of glial cells in the differentiating ES cells treated with fluoxetine. These results suggest that fluoxetine could facilitate the differentiation of mouse ES cells into glial cell lineage, which may affect fetal neural development.
Shinji Kusakawa; Kazuaki Nakamura; Yuki Miyamoto; Atsushi Sanbe; Tomohiro Torii; Junji Yamauchi; Akito Tanoue
Related Documents :
1718677 - The expression of tenascin by neural crest cells and glia.
14522877 - The rna-binding protein vg1 rbp is required for cell migration during early neural deve...
6796587 - An n-acetylgalactosaminyltransferase and its acceptor in embryonic chick neural retina ...
19590907 - Comparison of human dental follicle cells (dfcs) and stem cells from human exfoliated d...
8215297 - Inhibition of hiv-1 replication in cultured cells with phosphorylated dideoxyuridine de...
25310747 - Genistein decreases cellular redox potential, partially suppresses cell growth in hl‑60...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-20
Journal Detail:
Title:  Journal of neuroscience research     Volume:  88     ISSN:  1097-4547     ISO Abbreviation:  J. Neurosci. Res.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-10-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7600111     Medline TA:  J Neurosci Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3479-87     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Wiley-Liss, Inc.
Department of Pharmacology, National Research Institute for Child Health and Development, Setagaya, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Glial cell line-derived neurotrophic factor enhances in vitro differentiation of mid-/hindbrain neur...
Next Document:  Clinical implications of accessory pancreatic duct.